by: Elizabeth Balboa, Benzinga Staff Writer
CVS traded up 3.7 percent and Aetna 1.4 percent on the news, while Rite Aid Corporation RAD 6.71% fell 6.7 percent in sympathy and health insurers popped as much as 2.5 percent.
Why It's Important
The market’s positivity echoes that of health analysts deeming the merger a sensible survival strategy for firms in the age of Amazon.com, Inc. AMZN 0.89%.
“We see this potential deal as both evolutionary and revolutionary given the dynamic healthcare environment and push toward consumerism coupled with a challenged retail backdrop and the need to combat a looming AMZN threat,” Citigroup wrote in October.
Mizuho added that the union could set a precedent for the “next generation of formulary management in healthcare services.”
Some analysts have been less enthused, though, with Cantor Fitzgerald downgrading Aetna on the takeover risks.
CVS and Aetna have seen their stocks rise a respective 10.6 percent and 13.6 percent since rumors of the $66 million merger first emerged late October. Reuters reported the deal could close as early as December.
Aetna declined to comment on Thursday’s update.
Image Credit: hattiesburgmemory (CVS Pharmacy Uploaded by AlbertHerring) [CC BY 2.0], via Wikimedia Commons
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.